CN116648138A - Lactam composition and use - Google Patents
Lactam composition and use Download PDFInfo
- Publication number
- CN116648138A CN116648138A CN202180081479.4A CN202180081479A CN116648138A CN 116648138 A CN116648138 A CN 116648138A CN 202180081479 A CN202180081479 A CN 202180081479A CN 116648138 A CN116648138 A CN 116648138A
- Authority
- CN
- China
- Prior art keywords
- composition
- lactam
- solvent
- ethyl
- lactate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 76
- 150000003951 lactams Chemical class 0.000 title claims abstract description 67
- 239000002904 solvent Substances 0.000 claims abstract description 45
- 230000001580 bacterial effect Effects 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical class CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 38
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 30
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- GMEONFUTDYJSNV-UHFFFAOYSA-N Ethyl levulinate Chemical compound CCOC(=O)CCC(C)=O GMEONFUTDYJSNV-UHFFFAOYSA-N 0.000 claims description 22
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 claims description 19
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 18
- MRABAEUHTLLEML-UHFFFAOYSA-N Butyl lactate Chemical compound CCCCOC(=O)C(C)O MRABAEUHTLLEML-UHFFFAOYSA-N 0.000 claims description 12
- 239000001191 butyl (2R)-2-hydroxypropanoate Substances 0.000 claims description 12
- 229940116333 ethyl lactate Drugs 0.000 claims description 12
- 150000004730 levulinic acid derivatives Chemical class 0.000 claims description 11
- 150000003903 lactic acid esters Chemical class 0.000 claims description 10
- 150000001298 alcohols Chemical class 0.000 claims description 7
- HHCPGPHTKXVNHA-UHFFFAOYSA-N 4-(4-chlorophenyl)-5-methylidenepyrrol-2-one Chemical compound C1=CC(Cl)=CC=C1C1=CC(=O)NC1=C HHCPGPHTKXVNHA-UHFFFAOYSA-N 0.000 claims description 4
- 239000007853 buffer solution Substances 0.000 claims description 3
- 239000004744 fabric Substances 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims description 2
- 239000004033 plastic Substances 0.000 claims description 2
- 229920003023 plastic Polymers 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 239000002023 wood Substances 0.000 claims description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 36
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 239000000243 solution Substances 0.000 description 12
- 239000007787 solid Substances 0.000 description 11
- 238000005481 NMR spectroscopy Methods 0.000 description 10
- 239000004094 surface-active agent Substances 0.000 description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 7
- 239000000872 buffer Substances 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- YSZWLEFVAJQHJS-UHFFFAOYSA-N 5-methylidene-4-(4-methylphenyl)pyrrol-2-one Chemical compound C1=CC(C)=CC=C1C1=CC(=O)NC1=C YSZWLEFVAJQHJS-UHFFFAOYSA-N 0.000 description 4
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000002736 nonionic surfactant Substances 0.000 description 4
- 239000012044 organic layer Substances 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 4
- PZQOWENOZPCUSJ-UHFFFAOYSA-N 4-(4-chlorophenyl)-5-hydroxy-5-methyl-1H-pyrrol-2-one Chemical compound CC1(O)NC(=O)C=C1C1=CC=C(Cl)C=C1 PZQOWENOZPCUSJ-UHFFFAOYSA-N 0.000 description 3
- OVLMWAKWSBFBBQ-UHFFFAOYSA-N 4-(4-chlorophenyl)-5-hydroxy-5-methylfuran-2-one Chemical compound CC1(O)OC(=O)C=C1C1=CC=C(Cl)C=C1 OVLMWAKWSBFBBQ-UHFFFAOYSA-N 0.000 description 3
- CPAOXJPVYYJEAF-UHFFFAOYSA-N 5-hydroxy-5-methyl-4-(4-methylphenyl)-1H-pyrrol-2-one Chemical compound CC1=CC=C(C=C1)C1=CC(=O)NC1(C)O CPAOXJPVYYJEAF-UHFFFAOYSA-N 0.000 description 3
- JTBGHWGTJYXHMI-UHFFFAOYSA-N 5-hydroxy-5-methyl-4-(4-methylphenyl)furan-2-one Chemical compound CC1=CC=C(C=C1)C1=CC(=O)OC1(C)O JTBGHWGTJYXHMI-UHFFFAOYSA-N 0.000 description 3
- 125000002091 cationic group Chemical group 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000012258 stirred mixture Substances 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- -1 (4-chlorophenyl) -5-methylene-pyrrol-2-one Chemical compound 0.000 description 2
- JOOXCMJARBKPKM-UHFFFAOYSA-N 4-oxopentanoic acid Chemical compound CC(=O)CCC(O)=O JOOXCMJARBKPKM-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 239000008351 acetate buffer Substances 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- MOOYVEVEDVVKGD-UHFFFAOYSA-N oxaldehydic acid;hydrate Chemical compound O.OC(=O)C=O MOOYVEVEDVVKGD-UHFFFAOYSA-N 0.000 description 2
- 239000006174 pH buffer Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- WEJRYKSUUFKMBC-UHFFFAOYSA-N 1-(4-chlorophenyl)propan-2-one Chemical compound CC(=O)CC1=CC=C(Cl)C=C1 WEJRYKSUUFKMBC-UHFFFAOYSA-N 0.000 description 1
- NOXKUHSBIXPZBJ-UHFFFAOYSA-N 1-(4-methylphenyl)propan-2-one Chemical compound CC(=O)CC1=CC=C(C)C=C1 NOXKUHSBIXPZBJ-UHFFFAOYSA-N 0.000 description 1
- KVZLHPXEUGJPAH-UHFFFAOYSA-N 2-oxidanylpropanoic acid Chemical class CC(O)C(O)=O.CC(O)C(O)=O KVZLHPXEUGJPAH-UHFFFAOYSA-N 0.000 description 1
- JOOXCMJARBKPKM-UHFFFAOYSA-M 4-oxopentanoate Chemical class CC(=O)CCC([O-])=O JOOXCMJARBKPKM-UHFFFAOYSA-M 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000609240 Ambelania acida Species 0.000 description 1
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000010905 bagasse Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 150000003950 cyclic amides Chemical class 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940058352 levulinate Drugs 0.000 description 1
- 229940040102 levulinic acid Drugs 0.000 description 1
- 239000002029 lignocellulosic biomass Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/36—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- General Health & Medical Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Dentistry (AREA)
- Toxicology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The present invention relates to a composition comprising: (a) 0.0001-5 wt% of a lactam; and (b) 1-80 wt% solvent; wherein the composition has a pH of 4 to 6.50; wherein the lactam is selected from the following formulas. The invention also relates to a method of treating a surface to improve the resistance of the surface to bacterial fouling; and also to the use of a combination of a solvent in a lactam composition and a pH of 4 to 6.50 applied to the composition to improve the solubility and stability of the lactam in the composition.
Description
Technical Field
The present invention relates to improvements in the hygiene field, in particular to compositions comprising lactams, which exhibit improved lactam solubility and stability.
Background
Sanitation, particularly inhibition of bacterial species, is important to consumers.
Lactams are known as inhibitors of bacterial species. They may be applied to surfaces to inhibit bacterial species.
It is desirable to improve the usability of lactams and to provide formulations that exhibit improved lactam solubility and stability.
Disclosure of Invention
We have found that by formulating a composition comprising a lactam in combination with a solvent at a pH of 4-6.50, the resulting formulation exhibits improved solubility and stability of the lactam.
In a first aspect, the present invention relates to a composition comprising: -
(a) 0.0001 to 5 wt%, preferably 0.0001 to 2.5 wt%, more preferably 0.0001 to 1 wt%, and even more preferably 0.001 to 1 wt% of a lactam; and
(b) 0.5 to 95 wt%, preferably 0.5 to 90 wt%, more preferably 0.5 to 80 wt% of a solvent;
wherein the composition has a pH of 4 to 6.50, preferably a pH of 4 to 6.25, more preferably a pH of 4.50 to 6.00;
wherein the lactam is selected from the group consisting of:
and +.>
Preferably the pH is 4-5.40, more preferably 4.50-5.40.
More preferably, the lactam is selected from:
and/or +.>
Most preferably, the lactam is:
(4-chlorophenyl) -5-methylene-pyrrol-2-one.
Preferably, the lactam is delivered from a water-based composition, preferably it comprises 0.1 to 98 wt%, preferably 0.5 to 80 wt%, more preferably 1 to 75 wt% water.
The solvent is selected from: an alcohol; levulinate derivatives; lactic acid ester derivatives; and a solvent having a dielectric constant of 15 or more, preferably the solvent is selected from the group consisting of: alcohols, levulinate derivatives; and lactate derivatives; more preferably the solvent is selected from: levulinate derivatives and lactate derivatives.
Preferred examples of solvents are: alcohols, preferably C1-C4 alcohols, more preferably ethanol; lactate derivatives, preferably ethyl lactate and/or butyl lactate; levulinate derivatives, preferably 2-methyltetrahydrofuran, ethyl levulinate and/or ethyl Levulinate Glycerol Ketal (LGK); and a solvent having a dielectric constant of 15 or more, preferably Dimethylsulfoxide (DMSO).
Preferably, the solvent is selected from: ethanol; ethyl lactate, butyl lactate; 2-methyltetrahydrofuran, ethyl levulinate, and ethyl Levulinate Glycerol Ketal (LGK), or mixtures thereof.
Preferably, the solvent is selected from: levulinate derivatives; and lactate derivatives.
Most preferably, the solvent is selected from: ethyl lactate, butyl lactate; 2-methyltetrahydrofuran, ethyl levulinate, and ethyl Levulinate Glycerol Ketal (LGK), or mixtures thereof.
The solvent is present at a level of 0.5 to 95 wt%, preferably 0.5 to 90 wt%, more preferably 0.5 to 80 wt%. The solvent may be present at a minimum level of 0.5 wt%, 0.75 wt%, 1 wt%, 1.5 wt%, 2 wt%, 2.5 wt%, or even 5 wt%. The solvent may be present at a highest level of 95 wt%, 90 wt%, 85 wt%, 80 wt%, 70 wt%, 60 wt%, 50 wt%, 40 wt%, 30 wt%, 25 wt%, 20 wt%, or even 10 wt%. Any higher level of solvent is intended to be combinable with any lower level of solvent.
Preferably, the composition comprises one or more surfactants. The surfactant may be present at a level of from 0.25 to 25 wt%, preferably from 0.25 to 20 wt%, more preferably from 0.25 to 15 wt%, even more preferably from 0.25 to 10 wt%, or even from 0.5 to 10 wt% or even from 0.5 to 5 wt%.
The surfactant may be present at a level of from 0.25 to 25 wt%, preferably from 0.25 to 20 wt%, more preferably from 0.25 to 15 wt%, even more preferably from 0.25 to 10 wt%, or even from 0.5 to 10 wt% or even from 0.5 to 5 wt%.
The surfactant is preferably selected from anionic, nonionic, cationic and/or amphoteric surfactants. Preferred surfactants are nonionic surfactants.
The composition preferably comprises a buffer.
In a second aspect, the present invention relates to a method of treating a surface by treatment with a composition according to the first aspect of the invention to improve the resistance of the surface to bacterial contamination.
Preferably, the surface to be treated is selected from plastics, metals, wood, polymers, paper, fabrics and/or wipes.
Preferably, in the method, the lactam is selected from:
and/or +.>Preferably +.>
In a third aspect, the invention also relates to the use of a combination of a solvent in a lactam composition and a pH of 4-6.5, preferably 4-6.25, more preferably 4.50-6.00 applied to the composition for improving the solubility and stability of the lactam in the composition.
Preferably, in said use, the lactam is selected from:
and/or +.>Preferably +.>
Drawings
Fig. 1 is a photograph showing the solubility of lactam 488 at pH 5, pH 7 and pH 8.
Figure 2 shows the effect of pH on the solubility and stability of lactam 488. The initial solubility (left hand axis and rounded data points) and stability (right hand axis and square data points) of the lactam was delivered in ethanol to a total of 2% solvent and 100ppm lactam in solution vs buffer pH.
Detailed Description
The indefinite articles "a" or "an" and their corresponding definite articles "the" as used herein mean at least one, or one or more, unless otherwise specified.
It should be understood that all preferences are combinable unless explicitly stated otherwise.
Lactam
The lactam is a cyclic amide. The lactam is a lactam selected from the group consisting of:
more preferably, the lactam is selected from:
and/or +.>
Most preferably, the lactam is:
(4-chlorophenyl) -5-methylene-pyrrol-2-one.
When the lactam is cationic in nature, it may be used either as a cation or with a suitable counter ion (e.g. iodide).
Lactam level
Preferably the lactam is present at a level of 0.0001 to 2.5 wt%, preferably 0.0001 to 1 wt%. For example, the lactam may suitably be present at a level of 0.001 to 1 wt%, or even 0.01 to 0.5 wt%.
Composition and method for producing the same
Preferably, the lactam is delivered from a water-based composition, preferably it comprises 0.1 to 98 wt%, preferably 0.5 to 80 wt%, more preferably 1 to 75 wt% water. The composition may comprise any amount of water ranging from a lower amount of 0.1, 0.5, 1, 1.5, 2 or even 5 wt% water up to 30, 40, 50, 60, 70, 75, 80, 85, 90, 95, 96, 97, 98 or even 99 wt% water.
Solvent(s)
The composition comprises a solvent.
Preferred solvents are selected from: an alcohol; levulinate derivatives; lactic acid ester derivatives; and a solvent having a dielectric constant of 15 or more. Preferred examples of solvents are: alcohols, preferably C1-C4 alcohols, more preferably ethanol; lactate derivatives, preferably ethyl lactate and/or butyl lactate; levulinate derivatives, preferably 2-methyltetrahydrofuran, ethyl levulinate and/or ethyl Levulinate Glycerol Ketal (LGK); and a solvent having a dielectric constant of 15 or more, preferably Dimethylsulfoxide (DMSO).
Preferably, the solvent is selected from: ethanol; ethyl lactate, butyl lactate; 2-methyltetrahydrofuran (2 Me-THF), ethyl levulinate and ethyl Levulinate Glycerol Ketal (LGK), or mixtures thereof.
Preferably, the solvent is selected from: levulinate derivatives; and lactate derivatives.
Most preferably, the solvent is selected from: ethyl lactate, butyl lactate; 2-methyltetrahydrofuran, ethyl levulinate, and ethyl Levulinate Glycerol Ketal (LGK), or mixtures thereof.
2Me-THF, ethyl levulinate, and LGK can be categorized as levulinate derivatives (or levulinate derivatives). Levulinic acid can be derived from lignocellulosic biomass (i.e., corn hulls, bagasse, etc.), and can be converted to 2Me-THF in a cyclization reaction, ethyl levulinate in a one-step esterification, and LGK in two steps (esterification and ketal synthesis).
Ethyl lactate and butyl lactate are lactic acid (lactate) derivatives. Lactic acid is a byproduct of fermentation, which is then reacted with ethanol or butanol to produce ethyl lactate and butyl lactate.
The solvent is present at a level of 0.5 to 95 wt%, preferably 0.5 to 90 wt%, more preferably 0.5 to 80 wt%. The solvent may be present at a minimum level of 0.5 wt%, 0.75 wt%, 1 wt%, 1.5 wt%, 2 wt%, 2.5 wt%, or even 5 wt%. The solvent may be present at a highest level of 95 wt%, 90 wt%, 85 wt%, 80 wt%, 70 wt%, 60 wt%, 50 wt%, 40 wt%, 30 wt%, 25 wt%, 20 wt%, or even 10 wt%. Any higher level of solvent is intended to be combinable with any lower level of solvent.
The solvent may be present at a level of from 1 to 80 wt%, preferably from 1 to 50 wt%, more preferably from 1 to 40 wt%. The solvent level may also be 1 to 30 wt%, 1 to 20 wt%, or even 1 to 15 wt% or 1 to 10 wt%.
Preferably, the composition comprises one or more surfactants. The surfactant may be present at a level of from 0.25 to 25 wt%, preferably from 0.25 to 20 wt%, more preferably from 0.25 to 15 wt%, even more preferably from 0.25 to 10 wt%, or even from 0.5 to 10 wt% or even from 0.5 to 5 wt%.
The surfactant is preferably selected from anionic, nonionic, cationic and/or amphoteric surfactants. Preferred surfactants are nonionic surfactants.
The composition may preferably comprise a buffer to help maintain any resulting composition within a specified pH range. The buffer system may be any conventional buffer system known in the art. These may include, for example, citrate, acetate, phosphate and/or carbonate buffers, or mixtures thereof.
Further ingredients
The composition may comprise further ingredients such as surfactants, chelating agents, thickeners, pH modifiers and perfumes.
The invention will be further described by the following non-limiting examples.
Examples
Example 1 preparation of preferred lactam examples
Preparation of 4- (4-chlorophenyl) -5-hydroxy-5-methylfuran-2 (5H) -one
1- (4-chlorophenyl) propan-2-one (40.00 g,34.75mL,237.2 mmol), glyoxylate monohydrate (32.75 g,355.8 mmol) and phosphoric acid (69.74 g,711.7 mmol) were combined at room temperature and then heated to 85℃overnight. After cooling to room temperature, the mixture was poured into a mixture of water (500 mL) and ethyl acetate (500 mL). The layers were separated and the aqueous phase was extracted with ethyl acetate (500 mL). The combined organic layers were washed with a 1:1 mixture of water and brine (2×500 mL), dried (MgSO 4 ) And concentrated under reduced pressure to give 4- (4-chlorophenyl) -5-hydroxy-5-methylfuran-2 (5H) -one (66.00 g,>100% yield) as brown oilA shape. This material was used in the next step without further purification.
Preparation of 4- (4-chlorophenyl) -5-hydroxy-5-methyl-1H-pyrrol-2 (5H) -one
4- (4-chlorophenyl) -5-hydroxy-5-methylfuran-2 (5H) -one (66.00 g,293.8 mmol) was dissolved in thionyl chloride (196.8 g,120.0mL,1654 mmol) and heated at 40℃for 1 hour, then at 80℃for 2 hours. The mixture was concentrated under reduced pressure and azeotroped with 2-methyltetrahydrofuran (200 mL). The residue was diluted with 2-methyltetrahydrofuran (160 mL) and the solution was added to a cooled stirred mixture of 28% aqueous ammonia (180 mL) in 2-methyltetrahydrofuran (20 mL) at 0 ℃. The mixture was warmed to room temperature and stirred overnight. Water (100 mL) and ethyl acetate (200 mL) were added and the layers separated. The aqueous phase was extracted with ethyl acetate (200 mL) and the combined organic extracts were dried (MgSO 4 ) And concentrated under reduced pressure. Purification by dry flash column chromatography (5-60% ethyl acetate in heptane) afforded 4- (4-chlorophenyl) -5-hydroxy-5-methyl-1H-pyrrol-2 (5H) -one (23.18 g,35% yield) as a cream solid.
1 H NMR(400MHz,d 6 -DMSO)8.55(brs,1H),7.88-7.83(m,2H),7.51-7.46(m,2H),6.37(d,1H),6.32(s,1H),1.45(s,3H)
UPLC (alkaline) 1.51/5.00min,100% purity, M+H + 224
MP 177℃
Preparation of 4- (4-chlorophenyl) -5-methylene-1H-pyrrol-2 (5H) -one
To a cooled solution of 4- (4-chlorophenyl) -5-hydroxy-5-methyl-1H-pyrrol-2 (5H) -one (10.00 g,44.51 mmol) in anhydrous dichloromethane (100 mL) at 0deg.C for 15 min was added boron trifluoride etherate (8.213 g,7.142 mL)57.87 mmol) in anhydrous dichloromethane (45 mL). The mixture was stirred at 0 ℃ and then slowly warmed to room temperature and stirred for 2 hours. The reaction was quenched with ice water (100 mL) and the layers separated. The aqueous layer was extracted with dichloromethane (100 mL) and the combined organic layers were washed with a 1:1 mixture of water and saturated aqueous sodium bicarbonate (100 mL), dried (MgSO 4 ) And filtered. Silica was added to the filtrate and the mixture was stirred for 10 minutes, then filtered through a plug of silica, washed thoroughly with dichloromethane, then with a 3:1 mixture of dichloromethane and diethyl ether. . Fractions containing the desired product were combined and concentrated under reduced pressure. A precipitate formed upon concentration, which was collected by filtration, and washed with diethyl ether to give 4- (4-chlorophenyl) -5-methylene-1H-pyrrol-2 (5H) -one (5.25 g,57% yield) as a cream solid.
1 H NMR(400MHz,d 6 -DMSO)10.10(s,1H),7.54-7.47(m,4H),6.36(s,1H),5.04(t,1H),4.85(s,1H)
UPLC (alkaline) 1.87/5.00min,100% purity, M+H + 206
MP 182℃
Preparation of 5-hydroxy-5-methyl-4- (p-tolyl) furan-2 (5H) -one
1- (p-tolyl) propan-2-one (25.00 g,24.00mL,168.7 mmol), glyoxylate monohydrate (23.29 g,253.0 mmol) and phosphoric acid (49.60 g,506.1 mmol) were combined at room temperature and then heated overnight at 90 ℃. After cooling to room temperature, the mixture was poured into a stirred mixture of ice water (400 mL) and ethyl acetate (400 mL). The layers were separated and the organic phase was washed with water (100 mL), dried (MgSO 4 ) And concentrated under reduced pressure. The mixture was azeotroped with 2-methyltetrahydrofuran (50 mL) to give 5-hydroxy-5-methyl-4- (p-tolyl) furan-2 (5H) -one (16.50 g,48% yield) as a brown solid.
1 H NMR(400MHz,d 6 -DMSO)7.86(s,1H),7.75(d,2H),7.28(d,2H),6.59(s,1H),2.32(s,3H),1.61(s,3H)
Preparation of 5-hydroxy-5-methyl-4- (p-tolyl) -1H-pyrrol-2 (5H) -one
5-hydroxy-5-methyl-4- (p-tolyl) furan-2 (5H) -one (16.50 g,80.80 mmol) was dissolved in thionyl chloride (48.06 g,29.47mL,404.0 mmol) and heated at 50℃for 1 hour, then at reflux for 1 hour. After cooling to room temperature, the mixture was concentrated under reduced pressure and azeotroped with 2-methyltetrahydrofuran (2×50 mL). The residue was diluted with 2-methyltetrahydrofuran (60 mL) and the solution was added at 0deg.C to a cooled stirred mixture of 28% aqueous ammonia (55 mL,808.0 mol) in 2-methyltetrahydrofuran (10 mL). The mixture was warmed to room temperature and stirred overnight. The 2-methyltetrahydrofuran was removed under reduced pressure, the residue was diluted with water (200 mL) and diethyl ether (100 mL), and the mixture was stirred at room temperature for 20 min. The solid was collected by filtration and stirred at room temperature in water (100 mL) and diethyl ether (50 mL) for 10 min. The solid was collected by filtration, washed with water, diethyl ether, and dried under vacuum at 50 ℃ to give 5-hydroxy-5-methyl-4- (p-tolyl) -1H-pyrrol-2 (5H) -one (10.49 g,31% yield) as a pale beige solid.
1 H NMR(400MHz,d 6 -DMSO)8.44(brs,1H),7.73(d,2H),7.21(d,2H),6.24(s,2H),2.29(s,3H),1.45(s,3H)
13 C NMR(400MHz,d 6 -DMSO)170.4(s,1C),161.1(s,1C),139.8(s,1C),129.7(s,2C),128.9(s,1C),128.2(s,2C),119.1(s,1C),87.8(s,1C),26.7(s,1C),21.5(s,1C)
UPLC (alkaline) 1.41/5.00min,100% purity, M+H + 204
MP 178 ℃ decomposition
Preparation of 5-methylene-4- (p-tolyl) -1H-pyrrol-2 (5H) -one
To a cooled solution of 5-hydroxy-5-methyl-4- (p-tolyl) -1H-pyrrol-2 (5H) -one (8.68 g,42.7 mmol) in anhydrous dichloromethane (87 mL) was added a solution of boron trifluoride etherate (6.85 g,5.96mL,55.5 mmol) in anhydrous dichloromethane (40 mL) at 0deg.C over 15 min. After 1 hour, the mixture was allowed to slowly warm to room temperature. After a further 3 hours, the reaction was diluted with dichloromethane (50 mL) and ice water (100 mL) and stirred for 10 minutes. The layers were separated and the organic layer was washed with water (100 mL), a 1:1 mixture of water and saturated aqueous sodium bicarbonate (100 mL) and brine (100 mL) and the organic layer was filtered through celite, washing with dichloromethane. Any excess water was removed by pipette and the filtrate was dried (MgSO 4 ) And concentrated under reduced pressure to a brown solid. The solid was stirred in hot dichloromethane (120 mL) for 15 min, then slowly cooled to room temperature, and then cooled to 0 ℃. The solid was collected by filtration to give 5-methylene-4- (p-tolyl) -1H-pyrrol-2 (5H) -one (3.87 g,49% yield) as a yellow solid. Silica was added to the filtrate and the mixture was stirred for 10 minutes, then filtered through a plug of silica, washed thoroughly with dichloromethane, then with a 4:1 mixture of dichloromethane and diethyl ether. The filtrate was concentrated under reduced pressure to give 5-methylene-4- (p-tolyl) -1H-pyrrol-2 (5H) -one (0.58 g, 7%) as a yellow solid. Total yield of 5-methylene-4- (p-tolyl) -1H-pyrrol-2 (5H) -one (4.45 g,56% yield).
1 H NMR(400MHz,d 6 -DMSO)10.11(brs,1H),7.35(d,2H),7.25(d,2H),6.25(s,1H),5.01(s,1H),4.85(s,1H),2.31(s,3H)
UPLC (alkaline) 1.83/5.00min,100% purity, M+H + 186
MP 200 ℃ decomposition
The materials used
In the examples below, lactam 488 is used.
This is 4- (4-chlorophenyl) -5-methylene-pyrrol-2-one and the structure is shown below: -
Example 2
This example shows the effect of pH on the solubility of a lactam in a water-based composition comprising a solvent. A stock solution of lactam 488 at a target 10000ppm in ethanol was prepared and placed on a bottle roller (bottle roller) for 24 hours, then filtered through a syringe filter to produce a saturated solution (possibly about 8000ppm in ethanol). The stock solution was mixed with 0.1M acetate buffer at pH 5.2 or with 0.1M phosphate buffer at pH 7 or 8 in a ratio of 1:2, stirred in a vial and any precipitate formed was observed visually, indicating insolubility. From fig. 1 (glass picture) it can be seen that the lactam is mostly dissolved to an acceptable level at pH 5, whereas the solubility is greatly reduced at pH 7 and 8.
Example 3
This example demonstrates the lack of stability of the lactam composition at a pH below pH 4 and above pH 6.5.
Initial lactam solubility (3 hours) was measured by preparing a 5mg/ml solution of lactam 488 in ethanol. A 0.1M phosphate/citrate/carbonate mixed buffer was prepared and adjusted to a pH range of 2-10 (precise values in fig. 2 and table 1), then lactam 488/EtOH stock solution was added to a total of 2%, corresponding to the theoretical 100ppm lactam concentration in solution.
The solution was equilibrated for 3 hours, and then 200 μl of 7 replicates each was dispensed into a 96-well microtiter plate (Greiner, UV-Star), with well 8 as a background free of lactam. UV absorbance spectra were recorded in the range of 200-450nm on a Varioskan Lux UV/Vis plate reader to quantify the intensity of the lactam peak (lambda max =280 nm) and the signal was converted to ppm lactam in solution for calibration of the known EtOH/lactam solution.
Using a solution state 1 H NMR measured long term lactam stability. Lactam 488 was dissolved to a maximum concentration (10 mg/mL) in d6-DMSO and combined at a ratio of 2:1 with a series of pH buffers (pH 7.4.0.2M phosphate buffer, pH 6.1M citrate buffer, pH 5.2.0.1M acetate buffer)4, 2) and water. These samples were then filtered and inhibited by water 1 H NMR was studied at weekly time points for 4 weeks. The integration of the buffer peak was used to quantify the relative% of residual lactam compared to the lactam resonance at 5.22 ppm.
Results of lactam stability and solubility are shown in FIG. 2 for UV/Vis and 1 h NMR data showed. The values in fig. 2 are also shown in table 1.
pH buffer | Lactam concentration (3 hours) (ppm) | % residual lactam (4 weeks) |
2 | >80* | 20 |
3.12 | 80.53 | ~30* |
4.08 | 77.83 | 50 |
5.22 | 73.53 | 80 |
6.21 | 72.22 | 60 |
7.08 | 67.90 | 20 |
8.05 | 67.68 | <10* |
8.92 | 68.43 | 5 |
9.84 | 63.17 | <5* |
Table 1 initial concentrations calculated using UV/Vis spectroscopy, attenuation measured by NMR spectroscopy-values with x were not measured, but estimated by extrapolation from the plot
For compositions in which the pH is 4-6.5, the lactam only initially dissolves and exhibits long-term stability (4 weeks). Above this pH, the composition is not sufficiently soluble and is also unstable, while below pH 4, the composition is unstable.
Claims (14)
1. A composition comprising:
(a) 0.0001 to 5 wt%, preferably 0.0001 to 2.5 wt%, more preferably 0.0001 to 1 wt%, and even more preferably 0.001 to 1 wt% of a lactam; and
(b) 1 to 80 wt%, preferably 1 to 50 wt%, more preferably 1 to 40 wt% of a solvent;
wherein the composition has a pH of from 4 to 6.50, preferably from 4 to 6.25, more preferably from 4.50 to 6.00;
wherein the lactam is selected from the group consisting of:
and +.>
2. The composition according to claim 1, wherein the pH is 4-5.40, preferably 4.50-5.40.
3. The composition of claim 1 or claim 2, wherein the lactam is selected from the group consisting of:
and/or +.>
4. The composition of any one of the preceding claims, wherein the lactam is:
4- (4-chlorophenyl) -5-methylene-pyrrol-2-one.
5. The composition according to any of the preceding claims, wherein the composition is a water-based composition, preferably comprising 0.1 to 98 wt%, preferably 0.5 to 80 wt%, more preferably 1 to 75 wt% water.
6. The composition of any of the preceding claims, wherein the solvent is selected from the group consisting of: an alcohol; levulinate derivatives; lactic acid ester derivatives; and a solvent having a dielectric constant of 15 or more; preferably the solvent is: alcohols, preferably C1-C4 alcohols, more preferably ethanol; lactate derivatives, preferably ethyl lactate and/or butyl lactate; levulinate derivatives, preferably 2-methyltetrahydrofuran, ethyl levulinate and/or ethyl Levulinate Glycerol Ketal (LGK); and a solvent having a dielectric constant of 15 or more, preferably Dimethylsulfoxide (DMSO).
7. The composition of any of the preceding claims, wherein the solvent is selected from the group consisting of: ethanol; ethyl lactate, butyl lactate; 2-methyltetrahydrofuran, ethyl levulinate, and ethyl Levulinate Glycerol Ketal (LGK), or mixtures thereof; ethyl lactate and butyl lactate are preferred; 2-methyltetrahydrofuran, ethyl levulinate, and ethyl Levulinate Glycerol Ketal (LGK), or mixtures thereof.
8. The composition of any of the preceding claims, wherein the solvent is selected from the group consisting of: ethyl lactate, butyl lactate; 2-methyltetrahydrofuran, ethyl levulinate, and ethyl Levulinate Glycerol Ketal (LGK), or mixtures thereof.
9. The composition of any one of the preceding claims, wherein the composition comprises a buffer system.
10. A method of treating a surface by treatment with a composition according to any one of claims 1 to 9 to improve the resistance of the surface to bacterial fouling.
11. The method according to claim 10, wherein the surface to be treated is selected from plastic, metal, wood, polymer, paper, fabric and/or wipe.
12. The method of claim 10 or claim 11, wherein the lactam is selected from the group consisting of:
and/or +.>Preferably +.>
13. Use of a combination of a solvent in a lactam composition and a pH of 4-6.50 applied to the composition, preferably a pH of 4-6, more preferably a pH of 4.50-5.50, for improving the solubility and stability of the lactam in the composition.
14. The use according to claim 14, wherein the lactam is selected from the group consisting of:
and/or +.>Preferably +.>
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20212740.3 | 2020-12-09 | ||
EP20212740 | 2020-12-09 | ||
PCT/EP2021/080767 WO2022122265A1 (en) | 2020-12-09 | 2021-11-05 | Lactam composition and use |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116648138A true CN116648138A (en) | 2023-08-25 |
Family
ID=73789919
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202180081479.4A Pending CN116648138A (en) | 2020-12-09 | 2021-11-05 | Lactam composition and use |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP4258868A1 (en) |
CN (1) | CN116648138A (en) |
WO (1) | WO2022122265A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009069006A2 (en) * | 2007-11-30 | 2009-06-04 | Foamix Ltd. | Foam containing benzoyl peroxide |
DE212014000038U1 (en) * | 2013-02-01 | 2015-09-21 | Unilever N.V. | composition |
US10306886B2 (en) * | 2015-08-20 | 2019-06-04 | Conopco Inc. | Lactam solubility |
EP3849500A1 (en) * | 2018-09-14 | 2021-07-21 | Unilever Global Ip Limited | Mousse composition |
-
2021
- 2021-11-05 WO PCT/EP2021/080767 patent/WO2022122265A1/en active Application Filing
- 2021-11-05 CN CN202180081479.4A patent/CN116648138A/en active Pending
- 2021-11-05 EP EP21802747.2A patent/EP4258868A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2022122265A1 (en) | 2022-06-16 |
EP4258868A1 (en) | 2023-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3337451B1 (en) | Improved lactam solubility | |
EP2607363B1 (en) | Fused ring compound for use as mineralocorticoid receptor antagonist | |
WO2017029112A1 (en) | Lactam compositions | |
WO1999043678A1 (en) | Remedies/preventives for parkinson's disease | |
DE60314730T2 (en) | USE OF 4-AMINOPYRIMIDINES FOR ANTIMICROBIAL TREATMENT OF SURFACES | |
CN112689497B (en) | Mousse composition | |
CN116648138A (en) | Lactam composition and use | |
JP4986110B2 (en) | Melanin production inhibitor containing resorcinol derivative | |
CN109153683A (en) | 2H- chromene as NF- kB inhibitor simultaneously [2,3-D] pyrimidine -2,4 (3H)-diketone | |
KR20070042206A (en) | Method for manufacturing enantiomeric imidazole compounds | |
EP3337450B1 (en) | Improved lactam solubility | |
CN116669553A (en) | Lactam composition and use | |
EP3877471B1 (en) | Method of treatment of a surface | |
EP3385260A1 (en) | Novel hydroxyl pyranone compound, method for producing same, and cosmetics composition comprising compound | |
US11401240B2 (en) | Process for the synthesis of lactams | |
CN116583180A (en) | Lactam composition and use | |
CN112689664A (en) | Wiping article | |
EP3337449B1 (en) | Improved lactam solubility | |
KR100500503B1 (en) | Process for preparing a crystal 3-0-alkyl ascorbic acid | |
KR101625784B1 (en) | Ascorbic acid derivative composition and method for producing same, ascorbic acid derivative solution, and external preparation for skin | |
EP2885297B1 (en) | Trisubstituted pyrido[3,2-d]pyrimidines, their preparation process and their therapeutical uses | |
US10377707B2 (en) | Process for the preparation of lactams from glyoxalic acid | |
EP3712149B1 (en) | Benzamide derivative compound, method for preparing same, and pharmaceutical composition for treating or preventing inflammatory disease containing same as active ingredient | |
JP2005343964A (en) | Aqueous solution containing polyalkylene glycol and method for preparing the same | |
KR101569341B1 (en) | 4-(Arylureido)pyrrolidine derivatives inhibiting beta-secretase's activity and pharmaceutical composition containing the same as an active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |